Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor

Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor

US Patent 8993519 · Granted Mar 31, 2015

Estimated economic value: $233,578,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and apparatus for determining oil output quantity and gas output quantity2021
Shale oil in-situ lightening development method, apparatus and system2021
Composition comprising fluorine-containing ketone2021
Pharmaceutical compositions for an anti-CGRP antagonist antibody2021
Formulations of albu-BChE, preparation and uses thereof2016
Formulations of albu-BChE, preparation and uses thereof2016
Stable formulations of highly concentrated recombinant human albumin-human granu2012
Stable formulations of highly concentrated recombinant human albumin-human granu2012
Albumin fusion proteins2012
System and method for insulating skin from intravascular heat exchange catheter2005
Central venous catheter with heat exchange properties2003
Central venous catheter with heat exchange properties2002